Search - tctmd.com

Displaying 21 - 40 of 154

Sort: Relevancy | Date

News Industry News

Corvia Medical Announces Randomization of First Patient in the RESPONDER-HF Confirmatory Trial

December 06, 2022

News Daily News

Anatomic Features Key for Selecting Patients Best Suited to PFO Closure

Yael L. Maxwell

October 14, 2022

News Conference News TCT 2022

HF Devices Have a Role to Play, Even With Today’s GDMT Bonanza

Todd Neale

September 16, 2022

News Daily News

Antibiotics Before Invasive Dental Work Helpful in High-Risk Patients

Caitlin E. Cox

August 22, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for July 2022

Todd Neale

August 01, 2022

News Features

A Hole in the Heart for HFpEF? Setbacks, Progress for Interatrial Shunts

Shelley Wood

July 07, 2022

News Daily News

PFO Closure in Adults Over 60 Safe, but Patient Selection Key

Yael L. Maxwell

July 01, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2022

Shelley Wood

February 28, 2022

News Conference News THT 2022

Early Positive Signals From RELIEVE-HF Shift Discussion to Atrial Shunt Size

Shelley Wood

February 02, 2022

News Industry News

Landmark REDUCE LAP-HF II Trial Demonstrates Clinical Benefit of Corvia Atrial Shunt in Large Segment of Heart Failure Patients

February 02, 2022

News Conference News THT 2022

REDUCE LAP-HF II: Atrial Shunt Device Comes Up Short in HFpEF

Shelley Wood

February 01, 2022

News Daily News

PASCAL Pinpoints Patients With Strokes Causally Related to PFO

Yael L. Maxwell

December 20, 2021

News Daily News

CTO PCI Improves Total Myocardial Viability, PET Imaging Suggests

Yael L. Maxwell

December 13, 2021

News Daily News

Bioresorbable PFO/ASD Closure Device Shows Promise, but More Research Needed

Yael L. Maxwell

November 02, 2021

News Daily News

New Data Back Closing Large PFOs to Prevent Decompression Sickness in Divers

Yael L. Maxwell

August 19, 2021

News Industry News

First Five Patients Successfully Treated with atHeart Medical's Novel reSept™ Atrial Septal Defect Occluder in U.S. IDE Pivotal Trial

July 14, 2021

News Daily News

PFO Closure for Migraine: Pooled Analysis Hints at Benefit Over Meds Alone

Yael L. Maxwell

February 09, 2021

News CV Team Pro

NorthShore University Health System

L.A. McKeown

December 30, 2020

News Industry News

Corvia Medical Completes Randomization In Reduce Lap-Hf II Pivotal Trial And Gains Fda Authorization To Provide Continued Access For The Corvia Atrial Shunt

November 17, 2020

News Conference News TCT 2020

MITHRAS: No Upside to Closing iASDs Caused by Transcatheter MV Interventions

Shelley Wood

October 15, 2020

Advertisement

Corvia Medical Announces Randomization of First Patient in the RESPONDER-HF Confirmatory Trial

Anatomic Features Key for Selecting Patients Best Suited to PFO Closure

HF Devices Have a Role to Play, Even With Today’s GDMT Bonanza

Antibiotics Before Invasive Dental Work Helpful in High-Risk Patients

TCTMD’s Top 10 Most Popular Stories for July 2022

A Hole in the Heart for HFpEF? Setbacks, Progress for Interatrial Shunts

PFO Closure in Adults Over 60 Safe, but Patient Selection Key

TCTMD’s Top 10 Most Popular Stories for February 2022

Early Positive Signals From RELIEVE-HF Shift Discussion to Atrial Shunt Size

Landmark REDUCE LAP-HF II Trial Demonstrates Clinical Benefit of Corvia Atrial Shunt in Large Segment of Heart Failure Patients

REDUCE LAP-HF II: Atrial Shunt Device Comes Up Short in HFpEF

PASCAL Pinpoints Patients With Strokes Causally Related to PFO

CTO PCI Improves Total Myocardial Viability, PET Imaging Suggests

Bioresorbable PFO/ASD Closure Device Shows Promise, but More Research Needed

New Data Back Closing Large PFOs to Prevent Decompression Sickness in Divers

First Five Patients Successfully Treated with atHeart Medical's Novel reSept™ Atrial Septal Defect Occluder in U.S. IDE Pivotal Trial

PFO Closure for Migraine: Pooled Analysis Hints at Benefit Over Meds Alone

NorthShore University Health System

Corvia Medical Completes Randomization In Reduce Lap-Hf II Pivotal Trial And Gains Fda Authorization To Provide Continued Access For The Corvia Atrial Shunt

MITHRAS: No Upside to Closing iASDs Caused by Transcatheter MV Interventions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content